‘Pay Per Use’ model for the ulrich CTmotion™ and Max3™ injector
With the new ‘Pay Per Use’ model for the ulrich CTmotion™ and Max3™ injector, we offer our customers a cost-transparent and flexible solution for the procurement of contrast media injectors.
We thus enable billing per examination that is directly tailored to the individual needs and patient throughput of the facilities.
Pay Per Use Concept – Why?
TARDOC tariff system
The Swiss healthcare market is undergoing major changes and is facing further economic changes – the new TARDOC tariff system is due to be introduced in January 2026 and will cause further cost pressure.
Cost pressure
Many diagnostic institutes are already exposed to cost pressure due to inflation and other factors.
Cost transparency
There is often a lack of transparency regarding the total costs of use (TCU) of contrast media injectors – costs for purchasing, consumables and service are sometimes complex and it is difficult to maintain an overview.
Uncertainty
As a distributor of roller pump injectors, we are sometimes exposed to a great deal of scepticism from users regarding the ‘somewhat different’ technical concept of contrast medium injection using a roller pump injector.
Well-considered decisions
When switching to another injector manufacturer, you often have little or only a short opportunity to test the device – but what if you are not satisfied with the service or the device?
Innovation security
The release of new software or new hardware after international congresses surprises many – but what if you are always up to date with the latest software and can also make the decision in favour of new hardware after 24 months without any pressure?
Pay Per Use Concept – That’s why!
- We offer you an injector cost structure calculated for each individual examination – you can prepare for the TARDOC changes today.
- You can compare these values with your current cost structure as well as plan ahead for a period of 24 months
- you will be invoiced monthly or quarterly for the costs of use until the leasing contract comes to an end after 24 months
- Old software – problems with HW/SW updates? No problem – you can return the injector after 24 months and opt for a new device – so you are always up to date and have the latest device at your disposal
Pay Per Use – The Timeline
Pay per use concept – The Facts
Based on your patient mix (number of KM examinations per device per year), we jointly calculate the price per examination – the ‘Pay Per Use’
The term of the leasing contract is 24 months – the company MDL – Medical Devices Lease SA is our financing partner, who will invoice you monthly or quarterly for the costs of the injector.
The package includes:
- Injector
- 24 months warranty incl. full maintenance contract
Calculations based on 500 days of use or 250 days of use per year - Starter Kit – starter package for
Max3™ MR injector:
Approx. 90 days or 400 examinations (based on 1,250 KM examinations/year)
CTmotion™ CT injector:
Approx. 100 days or 700 examinations (based on 1,750 KM examinations/year) - Installation and training by our specialised technical and clinical staff
- Transparent residual value – at the end of the term after 24 months, you can buy the injector for a residual value and continue to use it
- or simply return the injector to MDL or to us and decide in favour of a new or different device.
- If you continue to use the injector and are satisfied with our service and the injector, you can buy the injector at the end of the 24 months. We will make you the following offer:
- Continuing contract for the supply of consumables
- Continuing full maintenance contract up to max. 8 years from the date of installation
- Financing conditions may vary – the officially issued and valid offer from Menges Medical Schweiz AG applies
Are you interested? Then please do not hesitate to contact us. We look forward to hearing from you.
Further information on the financing solutions can be found here.